Description

L?Arginine HCl combined with glucose supports detoxification by activating the urea cycle, facilitating hepatic ammonia clearance. The glucose portion supplies energy substrates, offsetting the catabolic stress during hepatic dysfunction. Primarily used in animal models of hepatic encephalopathy and acute hyperammonemia to study neuroprotection and detoxification pathways.

L?Arginine Hydrochloride & Glucose Product Specifications

L?Arginine Hydrochloride & Glucose Mechanism of Action

Arginine is a substrate in the urea cycle, converting ammonia into urea. Combined with glucose, it optimizes detoxification and energy supply in acute liver injury and ammonia metabolism. This formulation is used in models of hepatic encephalopathy and urea cycle dysfunction.

L?Arginine Hydrochloride & Glucose Research Application Areas

• Hepatic encephalopathy models: ammonia detox via urea cycle

• Hyperammonemia studies

• Ammonia metabolism & neuroprotection assays

• Glucose support in liver failure models

Safety & Handling

• Dosage in models: 15–20?g arginine IV over 4 hours for ammonia-lowering studies

• Side Effects: Generally mild; monitor glucose and electrolytes.

• Contraindications: Sodium-sensitive conditions, severe hyperglycemia, arginine hypersensitivity.

• Storage: Keep sealed at room temperature, away from light.

• Handling: Use under lab protocols with standard aseptic technique.

Core Keywords

L-arginine glucose injection, arginine HCl glucose 10g+25g, ammonia detox injection, hyperammonemia research, hepatic encephalopathy model, H20040530, lab-grade arginine glucose infusion

Research Use Disclaimer

This product is intended exclusively for laboratory and preclinical research use. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may pose health or regulatory risks. Use only under institutional protocols.